User Tools

Site Tools


documentation:oncology:meeting_notes_2019_sep-03

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Last revision Both sides next revision
documentation:oncology:meeting_notes_2019_sep-03 [2019/09/05 14:46]
mgurley
documentation:oncology:meeting_notes_2019_sep-03 [2019/09/05 17:22]
mgurley
Line 7: Line 7:
     * Rimma Belenkaya asked that logic for the SQL ETL should skip any schema with an ambiguous site/​histology combination in more than one NAACCR schema. ​ Not just ambiguous site/​histology combinations. ​ The group agreed to this. See here: https://​github.com/​OHDSI/​OncologyWG/​issues/​77.     * Rimma Belenkaya asked that logic for the SQL ETL should skip any schema with an ambiguous site/​histology combination in more than one NAACCR schema. ​ Not just ambiguous site/​histology combinations. ​ The group agreed to this. See here: https://​github.com/​OHDSI/​OncologyWG/​issues/​77.
     * We again reviewed the Symposium Vocabulary tasks: https://​github.com/​OHDSI/​OncologyWG/​issues?​q=is%3Aopen+is%3Aissue+label%3ASymposium+label%3AVocabulary     * We again reviewed the Symposium Vocabulary tasks: https://​github.com/​OHDSI/​OncologyWG/​issues?​q=is%3Aopen+is%3Aissue+label%3ASymposium+label%3AVocabulary
-      * There was discussion on whether to move Drug Treatment NAACCR item codes into the new '​Regimen'​ domain. ​ For the following issue: https://​github.com/​OHDSI/​OncologyWG/​issues/​69. ​ Mike Gurley raised that if we do this it leaves us without anything to put into the DRUG_EXPOSURE table. ​ So we should skip make any entry in DRUG_EXPOSURE for Drug Treatment NAACCR item codes. ​ Rimma argued if that if this is the case we should not move the DRUG Treatment NAACCR item codes into the Regimen domain. We should make them non-standard Drug domain entries and guide ETL developers to insert them as concept_id=0 but with the NAACCR concept in drug_source_concept_id. ​ And then create new or reuse high-level entries in the Regimen domain for the entry into Episode. ​ Rimma and Mike asked to create an entry in CONCEPT_RELATIONSHIP between the Drug Treatment NAACCR item codes and the high-level entries in the Regimen domain. ​ Christian Reich and Dymytry ​ argued that the CONCEPT_RELATIONSHIP entry is dirty and should not be done.  Insteady, they suggested ETL developers hardcode the mapping in their ETL logic. ​ Dymytry suggested re-using the Hemonc.org high-level '​Regimen Modality'​ concepts as the high-level concepts. ​+      * There was discussion on whether to move Drug Treatment NAACCR item codes into the new '​Regimen'​ domain. ​ For the following issue: https://​github.com/​OHDSI/​OncologyWG/​issues/​69. ​ Mike Gurley raised that if we do this it leaves us without anything to put into the DRUG_EXPOSURE table. ​ So we should skip making ​any entry in DRUG_EXPOSURE for Drug Treatment NAACCR item codes. ​ Rimma argued if that if this is the case we should not move the DRUG Treatment NAACCR item codes into the Regimen domain. We should make them non-standard Drug domain entries and guide ETL developers to insert them as concept_id=0 but with the NAACCR concept in drug_source_concept_id. ​ And then create new or reuse high-level entries in the Regimen domain for the entry into Episode. ​ Rimma and Mike asked to create an entry in CONCEPT_RELATIONSHIP between the Drug Treatment NAACCR item codes and the high-level entries in the Regimen domain. ​ Christian Reich and Dymytry ​ argued that the CONCEPT_RELATIONSHIP entry is dirty and should not be done.  Insteady, they suggested ETL developers hardcode the mapping in their ETL logic. ​ Dymytry suggested re-using the Hemonc.org high-level '​Regimen Modality'​ concepts as the high-level concepts. ​
       * Dymytry reported that all of the symposium vocabulary tasks would be fixed and published by 9/5/2019.       * Dymytry reported that all of the symposium vocabulary tasks would be fixed and published by 9/5/2019.
       * Jermey Warner gave more detail and explanation about ambiguities in Hemonc.org pointed out by Christian. ​ See here: https://​github.com/​OHDSI/​OncologyWG/​issues/​70#​issuecomment-527222143       * Jermey Warner gave more detail and explanation about ambiguities in Hemonc.org pointed out by Christian. ​ See here: https://​github.com/​OHDSI/​OncologyWG/​issues/​70#​issuecomment-527222143
documentation/oncology/meeting_notes_2019_sep-03.txt ยท Last modified: 2019/09/05 17:23 by mgurley